HIV-Related Cryptococcal Meningitis in Resource-Limited Settings

• Park BJ , WannemuehlerKA, MarstonBJ, GovenderN, PappasPG, ChillerTM: Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.AIDS23, 525–530(2009).
   PubMed Web of Science ®Google Scholar
• Mirza SA , PhelanM, RimlandDet al.: The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992–2000.Clin. Infect. Dis.36, 789–794(2003).
   PubMed Web of Science ®Google Scholar
• Dromer F , Mathoulin-PelissierS, FontanetA, RoninO, DupontB, LortholaryO; French Cryptococcosis Study G: Epidemiology of HIV-associated cryptococcosis in France (1985–2001): comparison of the pre and post-HAART eras. AIDS18, 555–562(2004).
   PubMed Web of Science ®Google Scholar
• Bekondi C , BernedeC, PassoneNet al.: Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus.Int. J. Infect. Dis.10, 387–395(2006).
   PubMed Web of Science ®Google Scholar
• Bogaerts J , RouvroyD, TaelmanHet al.: AIDS-associated cryptococcal meningitis in Rwanda (1983–1992): epidemiologic and diagnostic features.J. Infect.39, 32–37(1999).
   PubMed Web of Science ®Google Scholar
• Gordon SB , WalshAL, ChapondaMet al.: Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe, and seasonal.Clin. Infect. Dis.31, 53–57(2000).
   PubMed Web of Science ®Google Scholar
• Helbok R , PongpakdeeS, YenjunSet al.: Chronic meningitis in Thailand. Clinical characteristics, laboratory data and outcome in patients with specific reference to tuberculosis and cryptococcosis.Neuroepidemiology26, 37–44(2006).
   PubMed Web of Science ®Google Scholar
• Heyderman RS , GangaidzoIT, HakimJGet al.: Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe.Clin. Infect. Dis.26, 284–289(1998).
   PubMed Web of Science ®Google Scholar
• Hovette P , SokoTO, RaphenonG, CamaraP, BurgelPR, GarraudO: Cryptococcal meningitis in AIDS patients: an emerging opportunistic infection in Senegal.Trans. R. Soc. Trop. Med. Hyg.93, 368 (1999).
   PubMed Web of Science ®Google Scholar
• Schutte CM , Van der MeydenCH, MagaziDS: The impact of HIV on meningitis as seen at a South African Academic Hospital (1994 to 1998). Infection28, 3–7(2000).
   PubMed Web of Science ®Google Scholar
• Busari OA , QdeyemiAO, AgboolaSM: Cryptococcal meningitis in AIDS.Int. J. Infect. Dis.7(1) (2009).
   Google Scholar
• Kaplan JE , HansonD, DworkinMSet al.: Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.Clin. Infect. Dis.30, S5–S14 (2000).
   PubMed Web of Science ®Google Scholar
• van Elden LJ , WalenkampAM, LipovskyMNet al.: Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy.AIDS14, 2787–2788(2000).
   PubMed Web of Science ®Google Scholar
• Dore GJ , LiY, McDonaldA, ReeH, KaldorJM: National HIV Surveillance Committee. Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia.J. Acquir. Immune Defic. Syndr.29, 388–395(2002).
   PubMed Web of Science ®Google Scholar
• French N , GrayK, WateraCet al.: Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.AIDS16, 1031–1038(2002).
   PubMed Web of Science ®Google Scholar
• Kim JM , ChoGJ, HongSKet al.: Epidemiology and clinical features of HIV infection/AIDS in Korea.Yonsei Med. J.44, 363–370(2003).
   PubMed Web of Science ®Google Scholar
• Klotz SA , NguyenHC, Van PhamT, Nguyen LT, Ngo DT, Vu SN: Clinical features of HIV/AIDS patients presenting to an inner city clinic in Ho Chi Minh City, Vietnam. Int. J. STD AIDS18, 482–485(2007).
   PubMed Web of Science ®Google Scholar
• Kong BN , HarwellJI, SuosPet al.: Opportunistic infections and HIV clinical disease stage among patients presenting for care in Phnom Penh, Cambodia.Southeast Asian J. Trop. Med. Public Health38, 62–68(2007).
   PubMedGoogle Scholar
• Kumarasamy N , SolomonS, FlaniganTP, HemalathaR, ThyagarajanSP, MayerKH: Natural history of human immunodeficiency virus disease in southern India.Clin. Infect. Dis.36, 79–85(2003).
   PubMed Web of Science ®Google Scholar
• Mbanya DN , ZebazeR, MinkoulouEM, BinamF, KoullaS, ObounouA: Clinical and epidemiologic trends in HIV/AIDS patients in a hospital setting of Yaounde, Cameroon: a 6-year perspective.Int. J. Infect. Dis.6, 134–138(2002).
   PubMedGoogle Scholar
• Sacktor N , LylesRH, SkolaskyRet al.: HIV-associated neurologic disease incidence changes: multicenter AIDS cohort study, 1990–1998.Neurology56, 257–260(2001).
   PubMed Web of Science ®Google Scholar
• McCarthy KM , MorganJ, WannemuehlerKAet al.: Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence.AIDS20, 2199–2206(2006).
   PubMed Web of Science ®Google Scholar
• Subsai K , KanoksriS, SiwapornC, HelenL: Neurological complications in AIDS patients: the 1-year retrospective study in Chiang Mai University, Thailand.Eur. J. Neurol.11, 755–759(2004).
   PubMed Web of Science ®Google Scholar
• Corbett EL , ChurchyardGJ, CharalambosSet al.: Morbidity and mortality in South African gold miners: Impact of untreated disease due to human immunodeficiency virus.Clin. Infect. Dis.34, 1251–1258(2002).
   PubMed Web of Science ®Google Scholar
• Dromer F , Mathoulin-PelissierS, LaunayO, LortholaryO: Determinants of disease presentation and outcome during cryptococcosis: the CryptA/D Study. The French Cryptococcosis Study Group.PLoS Med.4(3), e21 (2007).
   PubMedGoogle Scholar
• Bekondi C , BernedeC, PassoneNet al.: Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus.Int. J. Infect. Dis.10, 387–395(2006).
   PubMed Web of Science ®Google Scholar
• Hakim JG , GangaidzoIT, HeydermanRSet al.: Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients.AIDS14, 1401–1407(2000).
   PubMed Web of Science ®Google Scholar
• Bicanic T , MeintjesG, WoodRet al.: Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.Clin. Infect. Dis.45, 76–80(2007).
   PubMed Web of Science ®Google Scholar
• Lortholary O , PoizatG, ZellerVet al.: Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.AIDS20, 2183–2191(2006).
   PubMed Web of Science ®Google Scholar
• Lawn SD , BekkerLG, MyerL, OrrellC, WoodR: Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme.AIDS19, 2050–2052(2005).
   PubMed Web of Science ®Google Scholar
• Aberg JA , PowderlyWG: Cryptococcosis.Adv. Pharmacol.37, 215–251(1997).
   PubMedGoogle Scholar
• Levltz SM : The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis.Rev. Infect. Dis.13(6), 1163–1169(1991).
   PubMedGoogle Scholar
• Speed B , DuntD: Clinical and host differences between infections with the two varieties of Cryptococcus neoformans.Clin. Infect. Dis.21, 28–35(1995).
   PubMed Web of Science ®Google Scholar
• Chemiak R , MorrisLC, BelayT, SpitzerED, LasadevallA: Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis.Infect. Immun.63, 1899–1905(1995).
   PubMed Web of Science ®Google Scholar
• Pukkila-Worley R , MylonakisE: Epidemiology and management of cryptococcal meningitis: developments and challenges.Expert Opin. Pharmacother.9, 551–560(2008).
   PubMed Web of Science ®Google Scholar
• Mitchell TG , PerfectJR: Cryptococcosis in the era of AIDS – 100 years after discovery of Cryptococcus neoformans.Clin. Microbiol. Rev.8(4), 515–548(1995).
   PubMed Web of Science ®Google Scholar
• McGuire D , BromleyE, AbergJet al.: Focal posterior-hemisphere invasive cryptococcal encephalitis - a distinct clinical-neuroimaging entity complicating cryptococcal meningitis in AIDS. Presented at: 122nd Annual Meeting of the American Neurological Association. 28September–1 October, San Diego, CA, USA (1997).
   Google Scholar
• Shelburne SA , VisnegarwalaF, DarcourtJet al.: Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.AIDS19, 399–406(2005).
   PubMed Web of Science ®Google Scholar
• Rambeloarisoa J , BatisseD, ThiebautJBet al.: Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS.J. Infect.44, 185–188(2002).
   PubMed Web of Science ®Google Scholar
• Breton G , DuvalX, EstellatCet al.: Determinants of immune reconstitution inflammatory syndrome in HIV type-1 infected patients with tuberculosis after initiation of antiretroviral therapy.Clin. Infect. Dis.39, 1709–1712(2004).
   PubMed Web of Science ®Google Scholar
• Lortholary O , FontanetA, MémainNet al.: Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France.AIDS19, 1043–1049(2005).
   PubMed Web of Science ®Google Scholar
• Jenny-Avital ER , AbadiM: Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy.Clin. Infect. Dis.15, 35(12), e128–33(2002).
   Google Scholar
• Makadzange AT , NdhlovuCE, TakarindaKet al.: Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa.Clin. Infect. Dis.50, 1532–1538(2010).
   PubMed Web of Science ®Google Scholar
• Kaplan JE , BensonC, HolmesKHet al.: Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents.MMWR Recomm. Rep.58, 1–207(2009).
   PubMedGoogle Scholar
• Shelburne SA 3rd, Darcourt J, White AC Jr et al.: The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin. Infect. Dis.40, 1049–1053(2005).
   PubMed Web of Science ®Google Scholar
• Lawn SD , BekkerLG, MyerL, OrrellC, WoodR: Cryptococcal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral program.AIDS19, 2050–2052(2005).
   PubMed Web of Science ®Google Scholar
• Saag MS , GraybillRJ, LarsenRAet al.: Practice guidelines for the management of cryptococcal disease.Clin. Infect. Dis.30, 710–718(2000).
   PubMed Web of Science ®Google Scholar
• Lortholary O : Management of cryptococcal meningitis in AIDS: the need for specific studies in developing countriesClin. Infect. Dis.45, 81–83(2007).
   PubMed Web of Science ®Google Scholar
• Currie BP , FreundlichLF, SotoMA, CasadevallA: False negative cerebrospinal fluid cryptococcal latex agglutination tests with culture positive cryptococcal meningitis.J. Clin. Microbiol.31(9), 2519–2522(1993).
   PubMed Web of Science ®Google Scholar
• Tanner DC , WeinsteinMP, FedorciwB, JohoKL, ThorpeJJ, RellerL: Comparison of commercial kits for detection of cryptococcal antigen.J. Clin. Microbiol.32(7), 1680–1684(1994).
   PubMed Web of Science ®Google Scholar
• Grant AD , De Cock KM: ABC of AIDS: HIV infection and AIDS in the developing world. BMJ.322, 1475–1478(2001).
   PubMed Web of Science ®Google Scholar
• van der Horst CM , SaagMS, CloudGAet al.: Treatment of cryptococcal meningitis associated with acquired immunodeficiency syndrome.N. Engl. J. Med.337, 15–21(1997).
   PubMed Web of Science ®Google Scholar
• Saag MS , GraybillRJ, LarsenRAet al.: Practice guidelines for the management of cryptococcal disease.Clin. Infect. Dis.30, 710–718(2000).
   PubMed Web of Science ®Google Scholar
• Larsen RA , LealMA, ChanLS: Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS: a randomized trial.Ann. Intern. Med.113, 183–187(1990).
   PubMed Web of Science ®Google Scholar
• Bicanic T , HarrisonT, NiepiekloA, DyakopuN, MeintjesG: Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution.Clin. Infect. Dis.43, 1069–1073(2006).
   PubMed Web of Science ®Google Scholar
• Graybill JR , SobelM, SaagMet al.: Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups.Clin. Infect. Dis.30(1), 47–54(2000).
   PubMed Web of Science ®Google Scholar
• Jaruratanasirikul S : Amphotericin B with or without flucytosine followed by fluconazole as a primary therapy for cryptococcal meningitis in patients with AIDS.Southeast Asian J. Trop. Med. Public Health.27(4), 719–723(1996).
   PubMedGoogle Scholar
• Ennis DM , SaagMS: Cryptococcal meningitis in AIDS.Hosp. Pract.28, 99–112(1993).
   PubMed Web of Science ®Google Scholar
• Lortholary O , NicolasM, SoredaSet al.: Fluconazole, with or without dexamethasone for experimental cryptococcosis: impact of treatment timing.J. Antimicrob. Chemother.43, 817–824(1999).
   PubMed Web of Science ®Google Scholar
• Ding JC , BauerM, DiamondDMet al.: Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis.Antimicrob. Agents Chemother.41, 1589–1593(1997).
   PubMed Web of Science ®Google Scholar
• Moskovitz BL , WiesingerB; Cryptoccocal Meningitis Research Group: Randomized comparative trial of Itraconazole and fluconazole for treatment of AIDS-related cryptococcal meningitis. Program and Abstracts of the 1st National Conference on Human Retroviruses and Related Infections. Washington DC, 12–16 December 1993 (Abstract A34).
   Google Scholar
• Bozzette SA , LarsenRA, ChinJet al.: A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immune deficiency syndrome. California Collaborative Treatment Group.N. Engl. J. Med.324, 580–584(1991).
   PubMed Web of Science ®Google Scholar
• Saag MS , CloudGA, GraybillJRet al.: A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.Clin. Infect. Dis.28, 291–296(1999).
   PubMed Web of Science ®Google Scholar
• Benson CA , KaplanJE, MasurH, PaciA, HolmesKK: Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health and the Infectious Disease Society of America.MMWR Recomm. Rep.53, 1–112(2004).
   PubMedGoogle Scholar
• Tiphine M , Letscher-BruU, HerbrechtR: Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy and tolerability.Transpl. Infect. Dis.28, 291–296(1999).
   Google Scholar
• Longley N , MuzooraC, TaseeraKet al.: Dose response effect of high dose Fluconazole for HIV associated cryptococcal meningitis in Southwestern Uganda.Clin. Infect. Dis.47, 1556–1561(2008).
   PubMed Web of Science ®Google Scholar
• Nussbaum J , JacksonA, NamarikaDet al.: Combination Flucytosine and high dose Fluconazole compared with Fluconazole monotherapy for the treatment of Cryptococcal meningitis: a randomized trial in Malawi.Clin. Infect. Dis.50, 338–344(2010).
   PubMed Web of Science ®Google Scholar
• Pitisuttithum P , NegroniR, GraybillJRet al.: Activity of Posconazole in the treatment of central nervous system fungal infections.J. Antimicrob. Chemother.56, 745–755(2005).
   PubMed Web of Science ®Google Scholar
• Esposito V , VigliettiR, GargiuloMet al.: Successful treatment of cryptococcal meningitis with a combination of liposomal amphotericin B, flucytosine and posaconazole: two case reports.In vivo23(3) 465–468(2009).
   PubMed Web of Science ®Google Scholar
• Notheis G , TaraniL, CostantinoF: Posaconazole for treatment of refractory invasive fungal disease.Mycoses49(Suppl. 1), 37–41(2006).
   PubMed Web of Science ®Google Scholar
• Dannaoui E , MeletiadisJ, MoutonJW, MeisJF, VerweijPE: Eurofung Network; in vitro susceptibilities of Zygomycetes to conventional and new antifungals.J. Antimicrob. Chemother.51, 45–52(2003).
   PubMed Web of Science ®Google Scholar
• Barchiesi F , SpreghiniE, SchimizziAMet al.: Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection.Antimicrob. Agents Chemother.48, 3312–3116(2004).
   PubMed Web of Science ®Google Scholar
• Hof H : A new broad spectrum antifungal: posaconazole-mechanisms of action and resistance, spectrum of activity.Mycoses49(Suppl.1), 2–6(2005).
   Web of Science ®Google Scholar
• Torres HA , HacherRY, ChemalyFR, KontoyiannisDP, RaadII: Posaconazole: a broad spectrum triazole antifungal.Lancet Infect. Dis.5, 775–785(2005).
   PubMed Web of Science ®Google Scholar
• Kambugu A , MeyaDB, O‘BrienMet al.: Outcomes of cryptococcal meningitis in Uganda Before and After the availability of Highly active aniretoviral therapy.Clin. Infect. Dis.46, 1694–1701(2008).
   PubMed Web of Science ®Google Scholar
• Lightowler VJ , CookeGS, MutevedziPet al.: Treatment of cryptococcal meningitis in KwaZulu-Natal, South Africa.PLoS One.5, E8630 (2010).
   PubMed Web of Science ®Google Scholar
• Micol R , LortholaryO, SarBet al.: Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.J. Acquir. Immune Defic. Syndr.45, 555–559(2007).
   PubMed Web of Science ®Google Scholar
• Liechty CA , SolbergP, WereWet al.: Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.Trop. Med. Int. Health.12, 929–935(2007).
   PubMed Web of Science ®Google Scholar
• Chetchotisakd P , SungkanuparphS, ThinkhamropB, MootsikapunP, BoonyaprawitP: A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency.HIV Med.5, 140–143(2004).
   PubMed Web of Science ®Google Scholar
• Tanner DC , WeinsteinMP, FedorciwB, JohoKL, ThorpeJJ, RellerL: Comparison of commercial kits for detection of cryptococcal antigen.J. Clin. Microbiol.32, 1680–1684(1994).
   PubMed Web of Science ®Google Scholar

Website

• International Network for the Study of HIV-Associated IRIS (INSHI). www.inshi.umn.edu
   Google Scholar